These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32795085)

  • 21. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
    Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigational small molecules in phase II clinical trials for the treatment of epilepsy.
    Greco M; Varriale G; Coppola G; Operto F; Verrotti A; Iezzi ML
    Expert Opin Investig Drugs; 2018 Dec; 27(12):971-979. PubMed ID: 30408428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of clinically significant anhedonia in refractory epilepsy.
    Wijayendran S; Jabr R; Roberts-West L; Bindman D; Walker MC; Baxendale S; Vivekananda U
    J Neurol Sci; 2024 Jan; 456():122826. PubMed ID: 38061273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant Classes and Possible Mechanism of Actions.
    Abd-Allah WH; El-Mohsen Anwar MA; Mohammed ER; El Moghazy SM
    ACS Chem Neurosci; 2023 Dec; 14(23):4076-4092. PubMed ID: 37948544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabidiol for Epilepsy: New Hope on the Horizon?
    Sanmartin PE; Detyniecki K
    Clin Ther; 2018 Sep; 40(9):1438-1441. PubMed ID: 30150078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.
    Szaflarski M; Hansen B; Bebin EM; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):364-369. PubMed ID: 28236578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exceptional response to brivaracetam in a patient with refractory idiopathic generalized epilepsy and absence seizures.
    Grande-Martín A; Sopelana-Garay D; Pardal-Fernández JM; Sánchez-Honrubia RM; Sánchez-Larsen ÁA
    Epileptic Disord; 2018 Feb; 20(1):60-64. PubMed ID: 29160210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.
    Campos G; Fortuna A; Falcão A; Alves G
    Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy.
    Deleo F; Quintas R; Turner K; Didato G; Zambrelli E; Pappalardo I; Chiesa V; Pastori C; de Curtis M; Canevini MP; Villani F
    Epilepsy Behav; 2019 Oct; 99():106391. PubMed ID: 31371205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of cannabidiol for seizure control in a patient with recurrent glioma.
    Hsu K; Whitham E; Kichenadasse G
    J Clin Neurosci; 2020 Jan; 71():275-276. PubMed ID: 31848037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of cannabis for treating children with refractory epilepsy.
    Neale M
    Nurs Child Young People; 2017 Sep; 29(7):32-37. PubMed ID: 29115760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.
    van der Poest Clement E; Jansen FE; Braun KPJ; Peters JM
    Paediatr Drugs; 2020 Feb; 22(1):73-84. PubMed ID: 31912454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance in epilepsy.
    Perucca E; Perucca P; White HS; Wirrell EC
    Lancet Neurol; 2023 Aug; 22(8):723-734. PubMed ID: 37352888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.
    Barker-Haliski ML; Johnson K; Billingsley P; Huff J; Handy LJ; Khaleel R; Lu Z; Mau MJ; Pruess TH; Rueda C; Saunders G; Underwood TK; Vanegas F; Smith MD; West PJ; Wilcox KS
    Neurochem Res; 2017 Jul; 42(7):1904-1918. PubMed ID: 28303498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies-An Italian observational multicenter study.
    De Liso P; Vigevano F; Specchio N; De Palma L; Bonanni P; Osanni E; Coppola G; Parisi P; Grosso S; Verrotti A; Spalice A; Nicita F; Zamponi N; Siliquini S; Giordano L; Martelli P; Guerrini R; Rosati A; Ilvento L; Belcastro V; Striano P; Vari MS; Capovilla G; Beccaria F; Bruni O; Luchetti A; Gobbi G; Russo A; Pruna D; Tozzi AE; Cusmai R
    Epilepsy Res; 2016 Nov; 127():93-100. PubMed ID: 27568598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamotrigine-resistant corneal-kindled mice: A model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery.
    Koneval Z; Knox KM; White HS; Barker-Haliski M
    Epilepsia; 2018 Jun; 59(6):1245-1256. PubMed ID: 29750337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sultiame revisited: treatment of refractory absence seizures.
    Gorman KM; Shahwan A
    Epileptic Disord; 2016 Sep; 18(3):329-33. PubMed ID: 27502446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A resurging boom in new drugs for epilepsy and brain disorders.
    Younus I; Reddy DS
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):27-45. PubMed ID: 28956955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE.
    Nogueira MH; Yasuda CL; Coan AC; Kanner AM; Cendes F
    Epilepsia; 2017 Jul; 58(7):1268-1276. PubMed ID: 28555776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.